Thursday, November 12, 2026
23 C
Bengaluru

Indian Pharma Market (IPM) Highlights – January 2025

Overall IPM Performance:

  • Monthly Growth: IPM monthly growth reached 8.4% in January 2025, following a pattern of significant monthly fluctuations throughout the year.
  • MAT Growth: The Moving Annual Total (MAT) growth for January 2025 slightly increased to 7.7%, up from 7.6% in December 2024.

Acute vs. Chronic Segment Analysis:

  • Chronic Segment Dominance: The chronic segment continued to outperform the acute segment, with a MAT growth of 9.9% compared to 6.3% for the acute segment in January 2025.
  • Growth Rate Declines: While the chronic segment's growth rate only slightly decreased (by 1.1%), the acute segment experienced a more substantial decline (3.2%) compared to January 2024.

Monthly Growth Trends:

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img